NHS England and NHS Improvement have released their guidance setting out the expectations for commissioners and providers in updating their operational plans for 2018/19.
But what does this updated guidance mean for pharma and medtech companies?
- What impact will additional funding provided have on the NHS?
- Which medicines will see a reduction in prescribing?
- What’s the future for STPs?
- What is an Integrated Care Systems and what are they responsible for?
- How will medicines optimisation affect primary care homes?
Complete the below form to download the full NHS Planning Guidance 2018/19 overview.